These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6122494)

  • 21. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reserpine-insensitive dopamine release in the substantia nigra?
    Elverfors A; Nissbrandt H
    Brain Res; 1991 Aug; 557(1-2):5-12. PubMed ID: 1720998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chlorpromazine and other anti-psychotic drugs on mouse striatal tyramines.
    Juorio AV
    Life Sci; 1977 May; 20(10):1663-7. PubMed ID: 17797
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.
    Andén NE; Svensson TH
    J Neural Transm; 1973; 34(1):23-30. PubMed ID: 4714591
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of in vivo amphetamine administration on dopamine synthesis regulation in rat brain striatal synaptosomes.
    Patrick RL; Berkowitz AL; Regenstein AC
    J Pharmacol Exp Ther; 1981 Jun; 217(3):686-91. PubMed ID: 7229999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pargyline and desmethylimipramine on monoamine concentrations and amphetamine-induced glycogenolysis in the mouse brain.
    Hutchins DA
    Br J Pharmacol; 1979 Mar; 65(3):489-94. PubMed ID: 427324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of tryptamine binding sites following chronic molindone administration. A comparison with responses of dopamine and 5-hydroxytryptamine receptors.
    Nguyen TV; Juorio AV
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):366-71. PubMed ID: 2586632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation by reserpine of the inhibition by amphetamine of (3H)dopamine accumulation in the rat striatum.
    Ross SB
    J Pharm Pharmacol; 1977 Jul; 29(7):433-4. PubMed ID: 19583
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors influencing brain and tissue levels of tryptamine: species, drugs and lesions.
    Sloan JW; Martin WR; Clements TH; Buchwald WF; Bridges SR
    J Neurochem; 1975 Mar; 24(3):523-32. PubMed ID: 1113126
    [No Abstract]   [Full Text] [Related]  

  • 32. Behavioural changes induced by N,N-dimethyl-tryptamine in rodents.
    Jenner P; Marsden CD; Thanki CM
    Br J Pharmacol; 1980 May; 69(1):69-80. PubMed ID: 6769527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injections of deuterated tryptamine into the nucleus accumbens of the rat: effects on locomotor activity and monoamine metabolism.
    Marien MR; Gerber R; Boyar WC; Altar CA
    Neuropharmacology; 1987 Oct; 26(10):1481-8. PubMed ID: 3683763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of various antipsychotic drugs upon the striatal concentrations of para-hydroxyphenylacetic acid and meta-hydroxyphenylacetic acid in the mouse.
    Juorio AV; McQuade PS
    Br J Pharmacol; 1983 Nov; 80(3):581-5. PubMed ID: 6196070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
    Fayle P; Jackson DM; Jenkins OF; Lafferty PA
    Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tranylcypromine and pargyline on brain tryptamine.
    Tabakoff B; Moses F; Philips SR; Boulton AA
    Experientia; 1977 Mar; 33(3):380-1. PubMed ID: 870336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
    Masuoka DT; Alcaraz AF; Schott HF
    Biochem Pharmacol; 1982 Jun; 31(11):1969-74. PubMed ID: 7115417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciclindole and flucindole: novel tetrahydrocarbazolamine neuroleptics.
    Wood PL; McQuade PS
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):773-7. PubMed ID: 6152347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of L-tryptophan on mouse brain 5-hydroxytryptamine: comparison of values obtained using a fluorimetric assay and a liquid Chromatographic assay with electrochemical detection.
    Marsden CA
    J Neurochem; 1981 May; 36(5):1621-6. PubMed ID: 7241125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
    J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.